From imaging to biology of glioblastoma: new clinical oncology perspectives to the problem of local recurrence

被引：9

作者：

Zygogianni, A. ^{[1
]}

Protopapa, M. ^{[1
]}

Kougioumtzopoulou, A. ^{[2
]}

Simopoulou, F. ^{[1
]}

Nikoloudi, S. ^{[1
]}

Kouloulias, V. ^{[2
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Aretaie Univ Hosp, Med Sch, Radiotherapy Unit,Dept Radiol 1, Athens, Greece

[2] Natl & Kapodistrian Univ Athens, ATTIKON Univ Hosp, Med Sch, Radiotherapy Unit,Dept Radiol 2, Rimini 1, Chaidari 12462, Greece

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2018年 / 20卷 / 08期

关键词：

Glioblastoma multiforme; Radiotherapy; Recurrence; Re-irradiation; Review; NEWLY-DIAGNOSED GLIOBLASTOMA; RANDOMIZED PHASE-III; MGMT PROMOTER METHYLATION; NEUTRON-CAPTURE THERAPY; HIGH-GRADE GLIOMAS; FRACTIONATED STEREOTACTIC RADIOTHERAPY; RECURSIVE PARTITIONING ANALYSIS; INTEGRATED GENOMIC ANALYSIS; CENTRAL-NERVOUS-SYSTEM; RADIATION-THERAPY;

D O I：

10.1007/s12094-018-1831-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

GBM is one of the most common and aggressive brain tumors. Surgery and adjuvant chemoradiation have succeeded in providing a survival benefit. Although most patients will eventually experience local recurrence, the means to fight recurrence are limited and prognosis remains poor. In a disease where local control remains the major challenge, few trials have addressed the efficacy of local treatments, either surgery or radiation therapy. The present article reviews recent advances in the biology, imaging and biomarker science of GBM as well as the current treatment status of GBM, providing new perspectives to the problem of local recurrence.

引用

页码：989 / 1003

页数：15

共 135 条

[1] REIRRADIATION OF LARGE-VOLUME RECURRENT GLIOMA WITH PULSED REDUCED-DOSE-RATE RADIOTHERAPY [J].

Adkison, Jarrod B. ;

Tome, Wolfgang ;

Seo, Songwon ;

Richards, Gregory M. ;

Robins, H. Ian ;

Rassmussen, Karl ;

Welsh, James S. ;

Mahler, Peter A. ;

Howard, Steven P. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (03) :835-841

[2] Imaging Genomics in Glioblastoma Multiforme: A Predictive Tool for Patients Prognosis, Survival and Outcome [J].

Anil, Rahul ;

Colen, Rivka R. .

MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2016, 24 (04) :731-+

[3] Survival analysis of HDR brachytherapy versus reoperation versus temozolomide alone: a retrospective cohort analysis of recurrent glioblastoma multiforme [J].

Archavlis, Eleftherios ;

Tselis, Nikolaos ;

Birn, Gerhard ;

Ulrich, Peter ;

Baltas, Dimos ;

Zamboglou, Nikolaos .

BMJ OPEN, 2013, 3 (03)

[4] A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas [J].

Arita, Hideyuki ;

Yamasaki, Kai ;

Matsushita, Yuko ;

Nakamura, Taishi ;

Shimokawa, Asanao ;

Takami, Hirokazu ;

Tanaka, Shota ;

Mukasa, Akitake ;

Shirahata, Mitsuaki ;

Shimizu, Saki ;

Suzuki, Kaori ;

Saito, Kuniaki ;

Kobayashi, Keiichi ;

Higuchi, Fumi ;

Uzuka, Takeo ;

Otani, Ryohei ;

Tamura, Kaoru ;

Sumita, Kazutaka ;

Ohno, Makoto ;

Miyakita, Yasuji ;

Kagawa, Naoki ;

Hashimoto, Naoya ;

Hatae, Ryusuke ;

Yoshimoto, Koji ;

Shinojima, Naoki ;

Nakamura, Hideo ;

Kanemura, Yonehiro ;

Okita, Yoshiko ;

Kinoshita, Manabu ;

Ishibashi, Kenichi ;

Shofuda, Tomoko ;

Kodama, Yoshinori ;

Mori, Kanji ;

Tomogane, Yusuke ;

Fukai, Junya ;

Fujita, Koji ;

Terakawa, Yuzo ;

Tsuyuguchi, Naohiro ;

Moriuchi, Shusuke ;

Nonaka, Masahiro ;

Suzuki, Hiroyoshi ;

Shibuya, Makoto ;

Maehara, Taketoshi ;

Saito, Nobuhito ;

Nagane, Motoo ;

Kawahara, Nobutaka ;

Ueki, Keisuke ;

Yoshimine, Toshiki ;

Miyaoka, Etsuo ;

Nishikawa, Ryo .

ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2016, 4 :79

[5] Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review [J].

Ashby, Lynn S. ;

Smith, Kris A. ;

Stea, Baldassarre .

WORLD JOURNAL OF SURGICAL ONCOLOGY, 2016, 14

[6] Quality assurance of the EORTC 26981/22981; NCICCE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review [J].

Ataman, F ;

Poortmans, P ;

Stupp, R ;

Fisher, B ;

Mirimanoff, RO .

EUROPEAN JOURNAL OF CANCER, 2004, 40 (11) :1724-1730

[7] Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institution [J].

Azoulay, Melissa ;

Santos, Fabiano ;

Souhami, Luis ;

Panet-Raymond, Valerie ;

Petrecca, Kevin ;

Owen, Scott ;

Guiot, Marie-Christine ;

Patyka, Mariia ;

Sabri, Siham ;

Shenouda, George ;

Abdulkarim, Bassam .

RADIATION ONCOLOGY, 2015, 10

[8] Radiation Therapy Dose Escalation for Glioblastoma Multiforme in the Era of Temozolomide [J].

Badiyan, Shahed N. ;

Markovina, Stephanie ;

Simpson, Joseph R. ;

Robinson, Clifford G. ;

DeWees, Todd ;

Tran, David D. ;

Linette, Gerry ;

Jalalizadeh, Rohan ;

Dacey, Ralph ;

Rich, Keith M. ;

Chicoine, Michael R. ;

Dowling, Joshua L. ;

Leuthardt, Eric C. ;

Zipfel, Gregory J. ;

Kim, Albert H. ;

Huang, Jiayi .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 (04) :877-885

[9] The role of brachytherapy in the treatment of glioblastoma multiforme [J].

Barbarite, Eric ;

Sick, Justin T. ;

Berchmans, Emmanuel ;

Bregy, Amade ;

Shah, Ashish H. ;

Elsayyad, Nagy ;

Komotar, Ricardo J. .

NEUROSURGICAL REVIEW, 2017, 40 (02) :195-211

[10] AVAREG: a phase 2, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma [J].

Brandes, Alba A. ;

Finocchiaro, Gaetano ;

Zagonel, Vittorina ;

Reni, Michele ;

Caserta, Claudia ;

Fabi, Alessandra ;

Clavarezza, Matteo ;

Maiello, Evaristo ;

Eoli, Marica ;

Lombardi, Giuseppe ;

Monteforte, Marta ;

Proietti, Emanuela ;

Agati, Raffaele ;

Eusebi, Vincenzo ;

Franceschi, Enrico .

NEURO-ONCOLOGY, 2016, 18 (09) :1304-1312

← 1 2 3 4 5 6 7 8 9 10 →